Philip Morris International Inc (PM) Analyst Ratings & Price Targets

Philip Morris International Inc

PM · NYSE

Analyst Consensus

Buy

15 analysts

$189

Current

—

Low

$211

Average

—

High

Average target implies +11.35% versus the current price.

The ratings synthesis for PM has not been generated yet.

Rating Actions

No individual rating actions have been captured for PMyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

B OF A GLBL RES

BARCLAYS CAPITA

CITIGROUP

CO FORECST

DEUTSCHE BK SEC

EDWARD JONES

GOLDMAN SACHS

JEFFERIES & CO.

JP MORGAN SECUR

MORGAN STANLEY

ROTHSCHILD REDB

STIFEL NICOLAUS

TD COWEN

UBS

ZACKS RESEARCH

Symbol: PM
Type: Stock
Sector: Health Care
Industry: Medicinal Chemicals and Botanical Products
Country: North America
Exchange: NYSE

Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI's first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes.

Analyst Consensus

See all

Buy